Kenvue and Kimberly-Clark are merging in a $32B deal with $2.1B in synergies and major consumer health potential. Learn why ...

We recently published 10 Stocks Soaring Past Expectations. Kenvue Inc. (NYSE:KVUE) is one of the big names that led last week ...

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

Kimberly-Clark Corp. shares fell the most in a quarter century after agreeing to buy Kenvue Inc., whose biggest product, ...

Texas officials have asked a state court judge to temporarily block Kenvue Inc. from marketing Tylenol as safe for pregnant ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

Texas Attorney General Ken Paxton on Thursday asked a state judge to block Kenvue from paying a nearly $400 million ...

Kleenex and Cottonelle maker Kimberly-Clark said it's buying Tylenol maker Kenvue in a $48.7 billion deal. Kenvue ( KVUE) ...

A number of prominent hedge funds are likely applauding Monday’s news that Kimberly-Clark Corp. has agreed to acquire Kenvue ...

The news comes as Kenvue maker Tylenol has been embroiled in litigation surrounding the alleged relationship between Tylenol ...

Kimberly-Clark will acquire Kenvue, the Johnson & Johnson spinoff, in a $48.7B cash and stock deal to create a global consumer health leader.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a huge consumer ...